Literature DB >> 6772670

Antibody-dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M, and A.

G H Lowell, L F Smith, J M Griffiss, B L Brandt, R P MacDermott.   

Abstract

We have compared the abilities of immunoglobulin (Ig)G, IgM, and IgA to induce either mononuclear cell-mediated (complement-independent) or complement-mediated (cell-free) antibacterial activity against group C meningococci. In each of these assays, immunoglobulins purified from the sera of individuals immunized with meningococcal group C polysaccharide were compared with those purified from sera of patients convalescing from disseminated meningococcal disease. Our data support three conclusions. First, although nonbactericidal in cooperation with complement, IgA can induce cell-mediated antibacterial activity as well as IgG. Second, the amount of IgG required to induce cell-mediated antibacterial activity is similar to the amount required for complement-mediated killing. Third, although the amount of either postimmunization or convalescent IgM required to induce complement-mediated killing is 16- to 20-fold less than the amount of respective IgG required, IgM is inferior to IgG in its ability to induce cell-mediated antibacterial activity because in the cell-mediated system (a) postimmunization IgM is ineffective; (b) the amount of convalescent IgM required for minimal activity is eightfold more than the amount of convalescent IgG required; and (c) the maximal antibacterial index induced by convalescent IgM is 50% less than that which can be induced by IgG. These data suggest that IgG and IgA may play a greater role than IgM in mononuclear cell-mediated antibacterial host immune defense.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772670      PMCID: PMC371706          DOI: 10.1172/JCI109852

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.

Authors:  W P Reed
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  New Classification of Neisseria meningitidis by Means of Bactericidal Reactions.

Authors:  R Gold; F A Wyle
Journal:  Infect Immun       Date:  1970-05       Impact factor: 3.441

3.  Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

4.  The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.

Authors:  F M Melewicz; S L Shore; E W Ades; D J Phillips
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Antibody-dependent cell-mediated antibacterial activity of human mononuclear cells. I. K lymphocytes and monocytes are effective against meningococi in cooperation with human imune sera.

Authors:  G H Lowell; L F Smith; M S Artenstein; G S Nash; R P MacDermott
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

6.  The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1970-03-01       Impact factor: 14.307

7.  Human immunity to Neisseria gonorrhoeae: acquired serum opsonic antibodies.

Authors:  A L Bisno; I Ofek; E H Beachey; R W Chandler; J W Curran
Journal:  J Lab Clin Med       Date:  1975-08

8.  Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

Authors:  H Y Reynolds; J A Kazmierowski; H H Newball
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

9.  Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.

Authors:  C E Frasch; L Parkes; R M McNelis; E C Gotschlich
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  20 in total

1.  Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.

Authors:  Joseph Martinez; Tamara Pilishvili; Suzanne Barnard; Joseph Caba; Willie Spear; Sandra Romero-Steiner; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine.

Authors:  A Aase; G Bjune; E A Høiby; E Rosenqvist; A K Pedersen; T E Michaelsen
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 3.  Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.

Authors:  M Kilian; J Mestecky; M W Russell
Journal:  Microbiol Rev       Date:  1988-06

Review 4.  Cellular immune responses during gonococcal and meningococcal infections.

Authors:  M D Cooper; E J Moticka
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

Review 5.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

6.  Antibody-dependent cell-mediated cytotoxicity against Escherichia coli O antigens.

Authors:  M Hagberg; S Ahlstedt; L Hanson
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

7.  Serum IgA: modulation of complement activation and induction of susceptibility to bacterial dissemination.

Authors:  J M Griffiss
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 8.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

9.  Activation of murine B lymphocytes by Neisseria meningitidis and isolated meningococcal surface antigens.

Authors:  J Melancon; R A Murgita; I W Devoe
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Effect of vitamin E on cell-mediated immune responses and serum corticosterone in young and maturing mice.

Authors:  T S Lim; N Putt; D Safranski; C Chung; R R Watson
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.